Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Curr Pharm Des. 2012;18(27):4215–4222. doi: 10.2174/138161212802430413

Figure 3.

Figure 3

Clotting assays were used to compare the anticoagulant activity of 3K3A-APC versus XIGRIS (wildtype recombinant APC) following their infusions in cynomolgus monkey at indicated doses (x-axis). Plasma samples were assayed as described in Methods section using aPTT assays and the aPTT prolongation data are shown in sec on y-axis; this prolongation reflects the dose-dependent anticoagulant activity of each form of APC.